Treatment Alert: How to Use Protease Inhibitors the Right Way

AUGUST 1997 UPDATE: HOW TO USE PROTEASE INHIBITORS THE RIGHT WAY by Richard Chara translated by MoL&66 Agosto his idaue oj NMAC's Treatment Alert i6 an updated verMion oj HOW TO USE PROTCASE INHIBITORS THE RIGHT WAY, originally publidhed in the Fall ot 1996. Ad alwayd, we encourage you to hare thid information with people living with HIV dideade and use a6 a tool to didcumd treatment optiond with dervice providers. Protease inhibitors are a new class of drugs used to stop the production of HIV in the body. Currently, there are 4 protease inhibitors available with a prescription: InviraseTM (saquinavir), NorvirTM (ritonavir), CrixivanTM (indinavir), and ViraceptTM (nelfinavir). It has been proven that using protease inhibitors, in combination with other anti-HIV drugs, can drive viral load measurements to levels below detection and increase CD4 cells for a long period of time. Studies are now being conducted to understand the best ways to use this new class of anti-HIV drugs. These studies address when to start treatment, when to switch treatment, which drugs are best for starting treatment, and which drugs are best for switching in case treatment fails. Even though there are still many questions about using protease inhibitors, we do know that they are very potent and effective drugs. Like all drugs, each protease inhibitor has different "advantages," "disadvantages" and "special considerations." These may influence your choice of treatment, and you should discuss them with a doctor, case manager or treatment advocate. Before choosing a protease inhibitor, or any anti-HIV drug, you should think about which drugs will work best with your lifestyle, eating habits, as well as in your work and home environments. take protease inhibitors and all anti-HIV drugs as prescribed. Never take "drug holidays" or doses less than what was prescribed in order to eliminate side effects. Do not skip doses. Taking less than the prescribed dose or skipping doses will cause you problems, including developing drug resistance. A successful regimen will be one to which you can adhere and one with which you can live. If you find that you are unable to take any drug because its side effects are too strong or because the schedule is too difficult to maintain, let your doctor know right away so that both of you can find a workable solution. Manufacturer: Roche Laboratories Call 1-800-910-4687 for general information about Invirase. Call 1-800-526-6367 for physician information. Call i-800-282-778o for patient assistance program information. Dose: 6oo mg (3 capsules 200 mg each) Dose Frequency: Every 8 hours (3 times per day) Special Considerations: Invirase must be taken with a full meal high in fat. Do not take Invirase on an empty stomach. Side Effects: Invirase seems to have the least potential for side effects. The side effects that have been observed in a few people include diarrhea, nausea, stomach discomfort, and sores in the mouth. Drug Interactions - Do not take Invirase with: * Calcium channel blockers * Cleocin (clindamycin) * Dapsone (dapsone) * Halcion (triazolam) * Hismanal (astemizole) * Mycobutin (rifabutin) * Propulsid (cisapride) * quinidine * rifampin (Rifadin, Rimactane, Rifamate, and Rifater) * Seldane (terfenadine) It is very important that all anti-HIV drugs be taken as prescribed, both in terms of doses and times. Always Nizoral (ketoconazole) - Be aware that Nizoral will elevate blood levels of Invirase. Consult with you doctor, if you are taking Invirase and Nizoral.

/ 6

Actions

file_download Download Options Download this page PDF - Pages 1-6 Image - Page 1 Plain Text - Page 1

About this Item

Title
Treatment Alert: How to Use Protease Inhibitors the Right Way
Author
National Minority AIDS Council
Canvas
Page 1 - Title Page
Publication
National Minority AIDS Council
1997-08
Subject terms
newsletters
Item type:
newsletters

Technical Details

Link to this Item
https://name.umdl.umich.edu/5571095.0291.008
Link to this scan
https://quod.lib.umich.edu/c/cohenaids/5571095.0291.008/1

Rights and Permissions

The University of Michigan Library provides access to these materials for educational and research purposes, with permission from their copyright holder(s). If you decide to use any of these materials, you are responsible for making your own legal assessment and securing any necessary permission.

Manifest
https://quod.lib.umich.edu/cgi/t/text/api/manifest/cohenaids:5571095.0291.008

Cite this Item

Full citation
"Treatment Alert: How to Use Protease Inhibitors the Right Way." In the digital collection Jon Cohen AIDS Research Collection. https://name.umdl.umich.edu/5571095.0291.008. University of Michigan Library Digital Collections. Accessed May 11, 2025.
Do you have questions about this content? Need to report a problem? Please contact us.